802 related articles for article (PubMed ID: 16445785)
1. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
2. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
3. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
Ponte P; Serrão V; Apetato M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
[TBL] [Abstract][Full Text] [Related]
7. 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial.
Tzaneva S; Kittler H; Holzer G; Reljic D; Weber M; Hönigsmann H; Tanew A
Br J Dermatol; 2010 Mar; 162(3):655-60. PubMed ID: 19769631
[TBL] [Abstract][Full Text] [Related]
8. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
9. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
10. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
Akita Y; Watanabe D; Yanagishita T; Kuhara T; Kawamura C; Masuda Y; Kawada M; Nakaseko H; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):95-7. PubMed ID: 17523931
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacokinetic and toxicologic profile of 8-methoxypsoralen. The basis for safe and effective PUVA therapy].
Schmid J; Brickl R; Koss FW
Derm Beruf Umwelt; 1988; 36(6):177-85. PubMed ID: 3069432
[TBL] [Abstract][Full Text] [Related]
12. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Inzinger M; Heschl B; Weger W; Hofer A; Legat FJ; Gruber-Wackernagel A; Tilz H; Salmhofer W; Quehenberger F; Wolf P
Br J Dermatol; 2011 Sep; 165(3):640-5. PubMed ID: 21564068
[TBL] [Abstract][Full Text] [Related]
14. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
15. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
16. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
[TBL] [Abstract][Full Text] [Related]
17. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
18. Methoxsalen photochemotherapy for mycosis fungoides.
Gilchrest BA
Cancer Treat Rep; 1979 Apr; 63(4):663-7. PubMed ID: 445518
[TBL] [Abstract][Full Text] [Related]
19. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
[TBL] [Abstract][Full Text] [Related]
20. Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.
Hernández Z; Peñate Y; Hernández-Machín B; Pérez-Méndez L; Suárez-Hernández J; Hernández J; Fernández-de-Misa R
Int J Dermatol; 2014 Nov; 53(11):1417-22. PubMed ID: 24697305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]